381 related articles for article (PubMed ID: 33201286)
1. Prediction of mediastinal lymph node metastasis based on
Yin G; Song Y; Li X; Zhu L; Su Q; Dai D; Xu W
Eur Radiol; 2021 Jun; 31(6):3983-3992. PubMed ID: 33201286
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic ability of
Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
[TBL] [Abstract][Full Text] [Related]
3. A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [
Rogasch JMM; Michaels L; Baumgärtner GL; Frost N; Rückert JC; Neudecker J; Ochsenreither S; Gerhold M; Schmidt B; Schneider P; Amthauer H; Furth C; Penzkofer T
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2140-2151. PubMed ID: 36820890
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
[TBL] [Abstract][Full Text] [Related]
5. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
Shigemoto Y; Suga K; Matsunaga N
Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128
[TBL] [Abstract][Full Text] [Related]
6. Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC.
Wang M; Liu L; Dai Q; Jin M; Huang G
J Cancer Res Clin Oncol; 2023 Jan; 149(1):247-261. PubMed ID: 36565319
[TBL] [Abstract][Full Text] [Related]
7. An [
Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M
Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809
[TBL] [Abstract][Full Text] [Related]
8. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
Zhai X; Guo Y; Qian X
Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
[TBL] [Abstract][Full Text] [Related]
10. Machine learning-based diagnostic method of pre-therapeutic
Yoo J; Cheon M; Park YJ; Hyun SH; Zo JI; Um SW; Won HH; Lee KH; Kim BT; Choi JY
Eur Radiol; 2021 Jun; 31(6):4184-4194. PubMed ID: 33241521
[TBL] [Abstract][Full Text] [Related]
11. [
Li Y; Zhang Y; Guo Z; Hou P; Lv J; Ke M; Liu S; Li S; Yin W; He J; Wang X
Cancer Imaging; 2024 Jun; 24(1):68. PubMed ID: 38831354
[TBL] [Abstract][Full Text] [Related]
12. Impact of EBUS-TBNA in addition to [
Guberina M; Darwiche K; Hautzel H; Ploenes T; Pöttgen C; Guberina N; Herrmann K; Umutlu L; Wetter A; Theegarten D; Aigner C; Eberhardt WEE; Schuler M; Karpf-Wissel R; Stuschke M
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2894-2903. PubMed ID: 33547554
[TBL] [Abstract][Full Text] [Related]
13. Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.
Rogasch JM; Apostolova I; Steffen IG; Steinkrüger FL; Genseke P; Riedel S; Wertzel H; Achenbach HJ; Kalinski T; Schultz M; Schreiber J; Amthauer H; Furth C
Eur J Radiol; 2016 Aug; 85(8):1345-50. PubMed ID: 27423672
[TBL] [Abstract][Full Text] [Related]
14. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P
PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598
[TBL] [Abstract][Full Text] [Related]
15. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
[TBL] [Abstract][Full Text] [Related]
16. AAR-LN-DQ: Automatic anatomy recognition based disease quantification in thoracic lymph node zones via FDG PET/CT images without Nodal Delineation.
Xu G; Udupa JK; Tong Y; Odhner D; Cao H; Torigian DA
Med Phys; 2020 Aug; 47(8):3467-3484. PubMed ID: 32418221
[TBL] [Abstract][Full Text] [Related]
17. Is Delayed Image of 18F-FDG PET/CT Necessary for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer Patients?
Lee SW; Kim SJ
Clin Nucl Med; 2022 May; 47(5):414-421. PubMed ID: 35234195
[TBL] [Abstract][Full Text] [Related]
18. The method and efficacy of support vector machine classifiers based on texture features and multi-resolution histogram from (18)F-FDG PET-CT images for the evaluation of mediastinal lymph nodes in patients with lung cancer.
Gao X; Chu C; Li Y; Lu P; Wang W; Liu W; Yu L
Eur J Radiol; 2015 Feb; 84(2):312-7. PubMed ID: 25487819
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.
Saydam O; Gokce M; Kilicgun A; Tanriverdi O
Med Oncol; 2012 Jun; 29(2):589-94. PubMed ID: 21380783
[TBL] [Abstract][Full Text] [Related]
20. Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2.
Pahk K; Chung JH; Yi E; Kim S; Lee SH
Eur J Radiol; 2018 Sep; 106():145-149. PubMed ID: 30150037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
